Bupropion Hydrochloride is used as an antidepressant medication to treat major depressive disorder and seasonal affective disorder Drug firm Granules India announced that it has received US FDA approval to market Bupropion Hydrochloride extended-release tablets, an antidepressant medication to treat major depressive disorder and seasonal affective disorder. "Granules Pharmaceuticals, Inc (GPI), a wholly-owned subsidiary of the company, has received approval from the US Food & Drug Administration (USFDA) to market the product in strengths of 150 mg and 300 mg," the drug firm said in a statement. The company
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!